NCT07651852Recruiting
Globe Registry: Globe® Pulsed Field System Registry Study for Treating Patients With Symptomatic Atrial Fibrillation
Source: ClinicalTrials.gov · Last updated 26 Oct 2026
Brief summary (registry, in English)
This post-market registry is designed to collect real world data on the use of the Globe PF System for the treatment of atrial fibrillation (AF).
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 500 (estimated)
- First submitted
- 11 Jun 2026
- Start date
- 9 Oct 2026
- Primary completion date
- Oct 2029
- Lead sponsor
- Kardium Inc.
- Diseases
- Atrial fibrillation
- NCT number
- NCT07651852
What you commit to
- Study type: Observational
- Planned participants: 500
- From 9 Oct 2026 to the primary completion date, Oct 2029
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Current enrollment in any investigational study of a medical device, biologic, or drug not pre-approved by Kardium
Other
- Patients whose life expectancy is 1 year or less
- Contraindication to left atrial catheter ablation or PF ablation
Who the study is looking for
- Patients with a planned ablation procedure using the commercially available Globe PF System
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Overlake Hospital Coordinator of this site? Confirm its status | Bellevue | United States | Recruiting |
| Arrhythmia Research Group Coordinator of this site? Confirm its status | Jonesboro | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.